HITIQ Limited (ASX:HIQ) Announces Entitlement Issue to Raise up to $2.92 Million
HITIQ Limited (ASX:HIQ) launches a non-renounceable entitlement issue aiming to raise up to $2.92 million to expand manufacturing and USA operations.
Category: Healthcare
Chimeric Therapeutics (ASX:CHM) Reports Positive ADVENT-AML Trial Results
Chimeric Therapeutics (ASX:CHM) reports that two of three patients achieved complete response in its ADVENT-AML Phase 1B clinical trial.
Epsilon Healthcare Limited (ASX:EPN) Announces Issue of $1M Loan Notes
Epsilon Healthcare Limited (ASX:EPN) issues loan notes to raise $1 million for operational expansion and diversification.
Mayne Pharma (ASX:MYX) Receives Court Approval for Acquisition Scheme
Mayne Pharma (ASX:MYX) receives Supreme Court approval for Cosette Pharmaceuticals’ acquisition scheme, leading to an upcoming shareholder vote.
Mesoblast (ASX:MSB) Receives 7-Year FDA Orphan Drug Approval for Ryoncil™
Mesoblast (ASX:MSB) secures 7-year FDA orphan-drug exclusivity for Ryoncil™ in treating pediatric SR-aGvHD, strengthening its IP protection.
Austco Healthcare Limited (ASX:AHC) Secures $2.1M Contract with Toronto Western Hospital
Austco Healthcare (ASX:AHC) secures a $2.1M contract to implement its nurse call platform at Toronto Western Hospital, enhancing its North American presence.
Lumos Diagnostics (ASX:LDX) Secures Largest FebriDx Purchase Order with iMedical
Lumos Diagnostics (ASX:LDX) announces its largest purchase order for FebriDx, reflecting increased US adoption and market acceptance.
Anteris Technologies Global Corp (ASX: AVR) Reports Q1 2025 Results
Anteris Technologies Global Corp (ASX: AVR) reports a 27% decline in Q1 sales and a 22% increase in operating loss, emphasizing strategic developments.
Optiscan Imaging Ltd (ASX:OIL) Advances Robotic Surgery Collaboration with Mayo Clinic
Optiscan Imaging Ltd (ASX:OIL) advances its collaboration with Mayo Clinic to develop advanced imaging systems for robotic surgery.
Wellnex Life Limited (ASX:WNX) Reports 46% Revenue Growth and AIM Listing
Wellnex Life Limited (ASX:WNX) reports a 46% revenue increase for Q1 2025 and completes AIM Market listing to strengthen its financial position.